Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma

Background and Objective. The features of asthma are airway inflammation, reversible airflow obstruction, and an increased sensitivity to bronchoconstricting agents, termed airway hyperresponsiveness (AHR), excess production of Th2 cytokines, and eosinophil accumulation in the lungs. To investigate...

Full description

Saved in:
Bibliographic Details
Main Authors: Seung-Hyung Kim, Bok-Kyu Kim, Young-Cheol Lee
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2011/485402
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850157972167065600
author Seung-Hyung Kim
Bok-Kyu Kim
Young-Cheol Lee
author_facet Seung-Hyung Kim
Bok-Kyu Kim
Young-Cheol Lee
author_sort Seung-Hyung Kim
collection DOAJ
description Background and Objective. The features of asthma are airway inflammation, reversible airflow obstruction, and an increased sensitivity to bronchoconstricting agents, termed airway hyperresponsiveness (AHR), excess production of Th2 cytokines, and eosinophil accumulation in the lungs. To investigate the antiasthmatic potential of hesperidin as well as the underlying mechanism involved, we studied the inhibitory effect and anti-inflammatory effect of hesperidin (HPN) on the production of Th2 cytokines, eotaxin, IL-17, -OVA-specific IgE in vivo asthma model mice. Methods. In this paper, BALB/c mice were systemically sensitized to ovalbumin (OVA) followed intratracheally, intraperitoneally, and by aerosol allergen challenges. We investigated the effect of HPN on airway hyperresponsiveness, pulmonary eosinophilic infiltration, various immune cell phenotypes, Th2 cytokine production and OVA-specific IgE production in a mouse model of asthma. Results. In BALB/c mice, we found that HPN-treated groups had suppressed eosinophil infiltration, allergic airway inflammation, and AHR, and these occurred by suppressing the production of IL-5, IL-17, and OVA-specific IgE. Conclusions. Our data suggest that the therapeutic mechanism by which HPN effectively treats asthma is based on reductions of Th2 cytokines (IL-5), eotaxin, OVA-specific IgE production, and eosinophil infiltration via inhibition of GATA-3 transcription factor.
format Article
id doaj-art-62ce836dfd314da6a48b387d0540f3ab
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-62ce836dfd314da6a48b387d0540f3ab2025-08-20T02:24:00ZengWileyMediators of Inflammation0962-93511466-18612011-01-01201110.1155/2011/485402485402Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic AsthmaSeung-Hyung Kim0Bok-Kyu Kim1Young-Cheol Lee2Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 300-716, Republic of KoreaInstitute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 300-716, Republic of KoreaDepartment of Herbology, College of Oriental Medicine, Sangji University, Wonju 220-702, Republic of KoreaBackground and Objective. The features of asthma are airway inflammation, reversible airflow obstruction, and an increased sensitivity to bronchoconstricting agents, termed airway hyperresponsiveness (AHR), excess production of Th2 cytokines, and eosinophil accumulation in the lungs. To investigate the antiasthmatic potential of hesperidin as well as the underlying mechanism involved, we studied the inhibitory effect and anti-inflammatory effect of hesperidin (HPN) on the production of Th2 cytokines, eotaxin, IL-17, -OVA-specific IgE in vivo asthma model mice. Methods. In this paper, BALB/c mice were systemically sensitized to ovalbumin (OVA) followed intratracheally, intraperitoneally, and by aerosol allergen challenges. We investigated the effect of HPN on airway hyperresponsiveness, pulmonary eosinophilic infiltration, various immune cell phenotypes, Th2 cytokine production and OVA-specific IgE production in a mouse model of asthma. Results. In BALB/c mice, we found that HPN-treated groups had suppressed eosinophil infiltration, allergic airway inflammation, and AHR, and these occurred by suppressing the production of IL-5, IL-17, and OVA-specific IgE. Conclusions. Our data suggest that the therapeutic mechanism by which HPN effectively treats asthma is based on reductions of Th2 cytokines (IL-5), eotaxin, OVA-specific IgE production, and eosinophil infiltration via inhibition of GATA-3 transcription factor.http://dx.doi.org/10.1155/2011/485402
spellingShingle Seung-Hyung Kim
Bok-Kyu Kim
Young-Cheol Lee
Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
Mediators of Inflammation
title Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
title_full Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
title_fullStr Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
title_full_unstemmed Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
title_short Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma
title_sort antiasthmatic effects of hesperidin a potential th2 cytokine antagonist in a mouse model of allergic asthma
url http://dx.doi.org/10.1155/2011/485402
work_keys_str_mv AT seunghyungkim antiasthmaticeffectsofhesperidinapotentialth2cytokineantagonistinamousemodelofallergicasthma
AT bokkyukim antiasthmaticeffectsofhesperidinapotentialth2cytokineantagonistinamousemodelofallergicasthma
AT youngcheollee antiasthmaticeffectsofhesperidinapotentialth2cytokineantagonistinamousemodelofallergicasthma